The virus that changed medicine: innovation and collaboration in a global health crisis

ERS Vision Live panel discussion


In a time of extreme difficulty, with unprecedented pressure on health systems, this live discussion focused on the positive outcomes of the COVID-19 pandemic – highlighting the response of key stakeholders in terms of innovation and improved communications and collaborations, which all help to deliver better outcomes for patients and support healthcare systems worldwide.


  • Distribution and supply of essential medicines and medical devices
  • Novel vaccine development, regulatory approval and delivery
  • Rapid trials for evaluation of new therapies, vaccines, and respiratory devices in a pandemic
  • Better communications/digital health and support for healthcare professionals – and between all key stakeholders

The panel

ERS President Prof. Anita Simonds and ERS Science Council Chair Prof. Christopher E. Brightling will led the discussion and were joined by:

  • Dr Hans Kluge – WHO Regional Director for Europe
  • Manuela Buxo – Head of Europe at Sanofi Genzyme
  • Sir Stephen Holgate – Clinical Professor of Immunopharmacology, University of Southampton/Co-founder of Synairgen
  • Sir Menelas Pangalos, EVP & President BioPharmaceuticals R&D, AstraZeneca
  • Katrin Pucknat – CEO and President, ResMed Germany